Patent ID: 7968124

Claim:
A method of absorbing or adsorbing one or more compounds in vivo, comprising the steps of: identifying a patient who has or is suspected of having said one or more compounds in said patient's tissues or blood stream, said one or more compounds being selected from a drug, toxin, or exogenous or endogenous substance which satisfies one or more of the following criteria a) contiguous string or ring of at least six carbon atoms, b) solubility of at least 1% in alpha-tocopherol, c) an octanol-water partition coefficient equal to or greater than 100, d) lowers surface tension of water to less than 50 dynes/cm at concentrations of 1% or less, or e) contains a contiguous sequence of at least four hydrophobic amino acids; administering to said patient a liquid composition comprising particles stabilized in dispersion in a polar solvent, said particles consisting essentially of reversed cubic phase or reversed hexagonal phase material; and using said particles to absorb or adsorb said one or more compounds by solubilization or partitioning of said one or more compounds into said reversed cubic phase or reversed hexagonal phase material.